Featured Article
Indian mycologists discover world's most heat-resistant fungi
In a significant discovery that can be a major breakthrough in biotechnology, Indian mycologists have discovered fungi spores, considered as being able to withstand a temperature of 100-115 degrees celsius.
Spores are reproductive cells capable of developing into a new individual without fusion with another reproductive cell. The team of fungi researchers found the heat-resistant spores in dead leaves.
"It took us around one and a half years to arrive at our conclusion. It is a preliminary but significant finding. It is reported for the first time that fungi spores can survive even 115 degrees Celsius," T.S. Surayanarayanan, director of the Vivekananda Institute of Tropical Mycology (VINSTROM), said
Dr Reddy acquires JB chemical business in Russia
Pharma Major Dr Reddy's today informed BSE that it has entered into an agreement with JB Chemicals and Pharmaceuticals to acquire their pharmaceutical prescription portfolio in the Russia and other CIS regions, for Rs 155 crore.
Takeda resubmits NDA for new diabetes drug alogliptin
Takeda Pharmaceutical Co has resubmitted two New Drug Applications to regulators in the USA for its investigational type 2 diabetes therapy alogliptin and the fixed-dose combination of the drug and the Japanese drugmaker's Actos (pioglitazone).
New drug improves vision in patients with inherited blindness
A Newcastle University study has found that an experimental drug improves the vision and perception of colour in patients with Leber's Hereditary Optic Neuropathy (LHON), an inherited blindness. 
Flu "super antibody" may bring universal shot closer
Scientists have found a flu "super antibody" called FI6 that can fight all types of influenza A viruses that cause disease in humans and animals and say their discovery may be a turning point in the development of new flu treatments.
GlaxoSmithKline launches two drugs
Pharma major GlaxoSmithKline announced the launch of two drugs. The drugs -- Revolade and Votrient -- are targetted towards specicific patient categories.
India's Glenmark gets $15 mln from Salix for upgradation
Indian drugmaker Glenmark Pharmaceuticals said on Tuesday it has received $15 million from U.S.-based Salix Pharmaceuticals towards upgrading the manufacturing facility for HIV-associated diarrhea drug 'Crofelemer'.
FDA to slap notice on Hindustan Antibiotics for drug violation
The Pune division of the Food and Drug Administration (FDA) has decided to serve a show-cause notice to the public sector Hindustan Antibiotics Ltd (HAL) for violating norms with regards to drugs nearing their expiry date.
Pharma companies may get tax sops for clinical trials, patent filings
The Department of Pharmaceuticals is planning to recommend extension of tax benefits given to drug makers for in-house R&D and research work done outside the firm such as clinical trials, bio-equivalence studies, regulatory approvals and patent filings which could benefit most Indian drug companies.
Mobile app for conference highlights
Members of Doctors.net.uk, the professional network of doctors in the UK, can now keep abreast of the latest medical conferences via their smartphone, due to a new Conference Highlights app.
Apple has more cash than the US government
The company led by Steve Jobs is richer than Uncle Sam. , While the world's most powerful government has just $73.76 billion in its reserves, the world's top technology company has a neat cash pile of $75.87 billion
Hero Honda is now Hero MotoCorp Limited Two-wheeler major Hero Honda Motors said that it has certified its new brand identity as Hero MotoCorp Limited. The two companies had ended their 26-year old association to pursue their own goals in the huge Indian two-wheeler market.
Singham continues to dominate digital cinemas Bollywood star Ajay Devgan's action flick 'Singham' marked a successful return to the action packed films as the film will screen on 748 UFO digital theatres in second week post release.
| 
